Title
GENETIC STRUCTURE OF DRUG-RESISTANT Mycobacterium tuberculosis STRAINS IN PERU BASED ON HAPLOTYPES OBTAINED FROM A LINE PROBE ASSAY
Other title
ESTRUCTURA GENÉTICA DE CEPAS DROGORRESISTENTES DE Mycobacterium tuberculosis EN PERÚ BASADA EN HAPLOTIPOS OBTENIDOS DE UN ENSAYO CON SONDAS EN LÍNEA
Date Issued
01 January 2021
Access level
open access
Resource Type
journal article
Publisher(s)
Instituto Nacional de Salud
Abstract
Objective. To determine the genetic structure of drug-resistant strains of Mycobacterium tuberculosis that circulated throughout Peru during the years 2011-2015, by using haplotypes obtained from a line probe assay. Materials and methods. A total of 6589 samples that were admitted to the Instituto Nacional de Salud for routine diagnosis using the GenoType® MTBDRplus v2 assay were analyzed during the study period. Resistant haplotypes were created by concatenating 21 polymorphic sites of the evaluated genes using the line probe assay; and the association analysis was carried out with phenotypes obtained by the 7H10 agar ratio method. Results. The most frequent mutations were: RpoB S531L (55.4%) and rpoB D516V (18.5%) for rifampicin resistance, and katG S315T (59.5%) and inhA c-15t (25.7%) for isoniazid resistance. We obtained 13 representative haplotypes (87.8% of analyzed samples), 6 corresponded to the multidrug-resistant genotype, 4 to the isoniazid mono-resistant genotype and 3 to the rifampicin mono-resistant genotype. Eighteen regions and the province of Callao showed high haplotype diversity; four showed moderate diversity and two showed low diversity. Conclusions. Most regions showed high haplotype diversity; in addition, most drug-resistant strains of Mycobacterium tuberculosis were concentrated in the cities of Lima and Callao. Likewise, drugresistant Mycobacterium tuberculosis strains circulating in Peru mainly contain the genetic markers with the highest prevalence worldwide, which are associated with resistance to rifampicin and isoniazid.
Start page
577
End page
586
Volume
38
Issue
4
Language
Spanish
OCDE Knowledge area
Farmacología, Farmacia
Genética, Herencia
Subjects
Scopus EID
2-s2.0-85127403907
PubMed ID
Source
Revista Peruana de Medicina Experimental y Salud Publica
ISSN of the container
17264634
Sponsor(s)
Esta investigación fue subvencionada por el Instituto Nacional de Salud del Perú, el Programa Nacional de Innovación para la Competitividad y Productividad-INNOVATE Perú (contrato: 353-PNICP-PIAP-2014) y la Dirección de Investigación de la Universidad Peruana de Ciencias Aplicadas (código: B-074-2021).
Sources of information:
Directorio de Producción Científica
Scopus